stockrowMannKind Corporation (MNKD) vs Omeros Corporation (OMER)
- MannKind Corporation MNKD 3.92 +4.26%
- Omeros Corporation OMER 16.83 −1.41%
MannKind Corporation and Omeros Corporation are both Biotechnology companies. MannKind Corporation and Omeros Corporation are of similar size ($1.2B and $1.2B). MannKind Corporation has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 9.8×. Omeros Corporation grew revenue faster over the last twelve months: 36.3% against 31.7%. Omeros Corporation has the higher net margin (128.4% vs −18.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Omeros Corporation leads on 10 and MannKind Corporation on 6.
Valuation
Profitability
| Metric | MNKD | OMER | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 37.57% | 68.51% |
| Operating margin | (2.88%) | (74.88%) | 0.00% |
| Net margin | (18.10%) | 128.36% | 0.00% |
| Free cash flow margin | (18.97%) | (70.69%) | 0.00% |
| Return on equity | 182.90% | (89.15%) | (51.96%) |
| Return on assets | (12.29%) | 51.22% | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack